BARBARA PLEIMAN: Open Payments
NPI 1073007027 · SIDNEY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 99 payments from 17 companies in 2025. Trend: 2023 $662 · 2024 $1,053 · 2025 $1,600
Food & beverage: $1,596Education: $4
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $262 |
| Lundbeck LLC | 12 | $190 |
| ABBVIE INC. | 16 | $186 |
| Alkermes, Inc. | 11 | $167 |
| Janssen Pharmaceuticals, Inc | 9 | $146 |
| Braeburn Inc. | 7 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
| Indivior Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $60 |
Products named: REXULTI, ARISTADA, BRIXADI, SPRAVATO, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
